+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fibrin Sealant Market by Product Type, Application, End User, Formulation Type, Technology - Global Forecast to 2030- Product Image
Fibrin Sealant Market by Product Type, Application, End User, Formulation Type, Technology - Global Forecast to 2030- Product Image
Sale

Fibrin Sealant Market by Product Type, Application, End User, Formulation Type, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904497
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fibrin Sealant Market grew from USD 445.89 million in 2024 to USD 510.03 million in 2025. It is expected to continue growing at a CAGR of 14.12%, reaching USD 985.43 million by 2030.

Shaping the Future of Hemostasis with Fibrin Sealants

Fibrin sealants have emerged as a cornerstone in modern surgical care, offering unparalleled hemostatic control and tissue adhesion that transform patient outcomes. Originating from the natural coagulation cascade, these biocompatible adhesives mimic physiological clot formation, arresting bleeding rapidly while supporting tissue repair. Recent advances have refined both composition and delivery, enhancing ease of use in diverse clinical settings, from high-complexity hospital operating theaters to outpatient ambulatory surgical centers.

Beyond hemostasis, the unique properties of fibrin sealants-biodegradability, minimal inflammatory response, and capacity to deliver therapeutic agents-have expanded their applications. Surgeons now rely on them not only to seal sutures and graft interfaces but also to secure implants in orthopedic reconstruction and facilitate vascular anastomoses in cardiovascular bypass procedures. As healthcare systems prioritize minimally invasive techniques and faster patient recovery, the demand for effective adjunctive technologies like fibrin sealants will continue to rise.

Innovations and Regulatory Evolution Redefine the Market

The landscape of fibrin sealants is undergoing transformative shifts driven by innovations in formulation, application technology, and regulatory alignment. Formulation scientists have optimized polymer concentration and crosslinking agents to balance adhesion strength with resorption rates, enabling targeted performance for wound closure in dental or neurosurgical procedures. Concurrently, the introduction of spray-based delivery systems has streamlined application in minimally invasive and laparoscopic surgeries, reducing operative time and improving surgeon ergonomics.

On the regulatory front, harmonization across major markets has accelerated product approvals, while increased scrutiny of biologic manufacturing practices has elevated quality standards. Investments in scalable production and supply chain resilience are redefining competitive dynamics, as manufacturers seek to mitigate raw material shortages and ensure uninterrupted delivery to hospitals, clinics, and ambulatory centers. Moreover, digital integration-such as real-time usage tracking and inventory management-aligns with hospital initiatives to enhance efficiency and cost control, reinforcing the strategic importance of next-generation fibrin sealant systems.

Adapting to Tariff-Driven Supply Chain Dynamics

In 2025, the implementation of new United States tariffs has reverberated across the fibrin sealant supply chain, prompting manufacturers and distributors to reassess sourcing strategies and pricing models. Tariff adjustments on precursor proteins and specialized packaging components have elevated production costs for domestically manufactured sealants, narrowing profit margins. Several companies have responded by diversifying raw material procurement, shifting toward suppliers in tariff-free regions, and reevaluating localized production hubs to buffer against policy fluctuations.

This evolving tariff environment has also influenced end users, as hospitals and surgical centers negotiate longer purchasing cycles and seek volume-based discounts to contain budgetary pressures. The ripple effect is evident in the adoption of alternative hemostatic agents in price-sensitive markets, where value-based procurement increasingly dictates purchasing decisions. Nonetheless, innovative manufacturers that proactively optimized their supply chains and pursued regulatory waivers for critical components have maintained pricing stability, reinforcing their market resilience as they navigate the complexities of 2025’s tariff landscape.

Navigating Market Complexity through Strategic Segmentation

The diversity of product formulations, application techniques, and clinical end uses underscores the multifaceted nature of the fibrin sealant market. When examining product types, liquid formulations continue to dominate due to their established efficacy in standard surgical closures, while patch formats have gained traction for localized bleeding control and leak prevention in thoracic and abdominal procedures. Spray-based delivery vehicles, meanwhile, are rapidly encroaching on niches that demand precise coverage, notably in minimally invasive and cardiovascular valve repair contexts.

Application-driven segmentation reveals that cardiovascular surgery remains a primary revenue contributor, with applications ranging from coronary artery bypass grafting to complex valve repair demanding high-performance adhesives. In general surgery, abdominal wall closures and thoracic leak management likewise leverage fibrin sealants to reduce postoperative complications. Orthopedic applications span joint reconstruction and trauma fixation, where secure adhesion of grafts and implants can accelerate rehabilitation. Dental surgeries and wound care settings also benefit from the hemostatic and adhesive properties of these biologics, illustrating the broad clinical footprint of fibrin sealants.

The end-user segment is characterized by a tripartite concentration in hospitals, ambulatory surgical centers, and clinics. Hospitals, with their extensive procedural portfolios, represent the largest consumption base, while outpatient facilities capitalize on the efficiency and reduced recovery times enabled by rapid-acting sealants. Clinics, particularly specialized ophthalmic and dental centers, have adopted smaller-format kits, reflecting the growth of focused procedural environments.

Formulation type further delineates market dynamics, with pre-mixed single-use kits delivering convenience and consistency in high-volume settings, whereas two-component systems offer customizable dosing and extended shelf stability for specialized procedures. Technological innovation in delivery has yielded both manual applicators for low-throughput contexts and automated spray systems that integrate with laparoscopic instruments. The interplay of these segmentation factors illuminates diverse pathways for manufacturers to tailor product portfolios to specific clinical and operational requirements.

Capitalizing on Regional Diversity in Adoption Patterns

Regional dynamics in the fibrin sealant market reflect variations in healthcare infrastructure, reimbursement frameworks, and clinical practice norms across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced hospital networks and robust R&D investment fuel early adoption of next-generation sealants, while integrated procurement channels enable volume-based pricing agreements, fostering market growth despite occasional supply chain disruptions.

Across Europe, the Middle East & Africa region, a mosaic of public and private healthcare systems dictates diverse adoption rates. High-income European countries exhibit streamlined regulatory pathways and sophisticated surgical protocols, supporting penetration of both pre-mixed and spray-based formulations. In contrast, emerging markets within the Middle East and Africa demonstrate rising demand for cost-effective, user-friendly sealants, often driven by government-led initiatives to reduce perioperative complications.

Asia-Pacific presents a dual landscape. Established markets such as Japan, South Korea, and Australia continue to embrace premium sealant technologies, supported by favorable reimbursement policies and clinical guidelines prioritizing hemostatic efficiency. Rapidly developing markets in Southeast Asia and South Asia are experiencing accelerated hospital expansion and increasing surgical volumes, creating opportunities for manufacturers to introduce scalable production models and localized partnerships. These regional insights underscore the need for tailored market entry and growth strategies that align with local clinical, regulatory, and economic drivers.

Unveiling the Competitive Forces Driving Innovation

Leading players in the fibrin sealant arena have distinguished themselves through targeted innovation, strategic collaborations, and robust global footprints. Major biotechnology firms have invested heavily in pipeline development, focusing on enhanced formulations with controlled degradation kinetics and integrated antimicrobial properties. Partnerships between applicator manufacturers and surgical device companies have yielded hybrid systems that marry adhesive performance with ergonomic delivery, capturing surgeon preference in high-stakes procedural settings.

Smaller specialized companies have carved niches by offering customizable kits tailored to specific clinical segments, such as neurosurgery or wound care, leveraging direct engagement with key opinion leaders to accelerate adoption. Several entities have expanded manufacturing capacity through acquisitions of biologic production facilities, ensuring vertical integration and supply chain security. Moreover, distribution alliances across emerging markets have bolstered market access, enabling agile responses to regional procurement tender processes and aligning with healthcare providers seeking comprehensive service agreements.

Charting Strategic Paths to Market Leadership

To thrive in the evolving fibrin sealant landscape, industry leaders should prioritize a multi-pronged strategic approach. First, accelerating R&D initiatives that enhance formulation versatility and integrate therapeutic agents will address unmet clinical needs and differentiate product portfolios. Second, forging alliances with application device manufacturers can yield proprietary delivery systems that lock in surgeon loyalty and command premium pricing.

Third, strengthening supply chain resilience through diversified sourcing and regional manufacturing hubs will buffer against regulatory changes and tariff fluctuations. Fourth, adopting digital engagement platforms to deliver continuous professional education and real-time usage analytics can deepen customer relationships and inform product improvements. Finally, tailoring market entry strategies to regional nuances-such as adapting pricing models for cost-sensitive markets in the Middle East & Africa and investing in value-based contracting in North America-will unlock new growth corridors and fortify competitive positioning.

Foundation of Rigorous Analysis and Industry Engagement

The research underpinning this analysis is grounded in a rigorous, multi-tiered methodology designed to ensure accuracy and relevance. Primary insights were obtained through interviews with leading healthcare practitioners, procurement specialists, and industry executives across key regions. Secondary sources, including peer-reviewed journals, regulatory filings, and financial reports, provided a robust framework for validating market trends and segmentation dynamics.

Quantitative data were triangulated with corporate disclosures and proprietary transaction databases to map supply chain flows and competitive market shares. Clinical trial registries and surgical outcome studies informed the assessment of product performance and adoption barriers. A cross-functional team of analysts synthesized evidence on technological innovations, policy developments, and tariff impacts, enabling a holistic perspective on the fibrin sealant market. Throughout the process, iterative peer reviews and quality checks ensured methodological consistency and minimized bias.

Seizing the Moment to Drive Advanced Surgical Solutions

The fibrin sealant market stands at a pivotal juncture, propelled by advances in formulation science, delivery technologies, and global healthcare dynamics. As clinical demand intensifies for minimally invasive procedures and enhanced patient outcomes, fibrin sealants are poised to play an even more central role in surgical protocols. Yet, navigating the complexities of tariff shifts, regional adoption patterns, and competitive innovation will require strategic foresight and operational agility.

Manufacturers and stakeholders who align product development with evolving clinical needs, reinforce supply chain robustness, and tailor market strategies to regional characteristics will capture the greatest value. The insights presented herein illuminate the pathways to sustainable growth and underscore the importance of continuous adaptation in a dynamic environment. Ultimately, the organizations that leverage comprehensive market intelligence and foster collaborative partnerships will set the standard for excellence in the fibrin sealant domain.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Liquid
    • Patch
    • Spray
  • Application
    • Cardiovascular
      • Bypass
      • Valve Repair
    • Dental
    • General Surgery
      • Abdominal
      • Thoracic
    • Neurosurgery
    • Orthopedic
      • Joint Reconstruction
      • Trauma Fixation
    • Wound Care
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
  • Formulation Type
    • Pre Mixed
    • Two Component Kits
  • Technology
    • Manual Application
    • Spray Application
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Baxter International Inc.
  • Ethicon Inc.
  • CSL Behring GmbH
  • B. Braun Melsungen AG
  • Omrix Biopharmaceuticals, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Hunan Kelun-Biotech Co., Ltd.
  • Shanghai Hualan Biological Engineering Inc.
  • Shanghai Haoyuan Biological Manufacturing Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Fibrin Sealant Market, by Product Type
8.1. Introduction
8.2. Liquid
8.3. Patch
8.4. Spray
9. Fibrin Sealant Market, by Application
9.1. Introduction
9.2. Cardiovascular
9.2.1. Bypass
9.2.2. Valve Repair
9.3. Dental
9.4. General Surgery
9.4.1. Abdominal
9.4.2. Thoracic
9.5. Neurosurgery
9.6. Orthopedic
9.6.1. Joint Reconstruction
9.6.2. Trauma Fixation
9.7. Wound Care
10. Fibrin Sealant Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
11. Fibrin Sealant Market, by Formulation Type
11.1. Introduction
11.2. Pre Mixed
11.3. Two Component Kits
12. Fibrin Sealant Market, by Technology
12.1. Introduction
12.2. Manual Application
12.3. Spray Application
13. Americas Fibrin Sealant Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Fibrin Sealant Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Fibrin Sealant Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Baxter International Inc.
16.3.2. Ethicon Inc.
16.3.3. CSL Behring GmbH
16.3.4. B. Braun Melsungen AG
16.3.5. Omrix Biopharmaceuticals, Inc.
16.3.6. Shanghai RAAS Blood Products Co., Ltd.
16.3.7. Hunan Kelun-Biotech Co., Ltd.
16.3.8. Shanghai Hualan Biological Engineering Inc.
16.3.9. Shanghai Haoyuan Biological Manufacturing Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. FIBRIN SEALANT MARKET MULTI-CURRENCY
FIGURE 2. FIBRIN SEALANT MARKET MULTI-LANGUAGE
FIGURE 3. FIBRIN SEALANT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FIBRIN SEALANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. FIBRIN SEALANT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. FIBRIN SEALANT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FIBRIN SEALANT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FIBRIN SEALANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FIBRIN SEALANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FIBRIN SEALANT MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FIBRIN SEALANT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FIBRIN SEALANT MARKET SIZE, BY BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FIBRIN SEALANT MARKET SIZE, BY VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FIBRIN SEALANT MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FIBRIN SEALANT MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FIBRIN SEALANT MARKET SIZE, BY THORACIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FIBRIN SEALANT MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FIBRIN SEALANT MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FIBRIN SEALANT MARKET SIZE, BY TRAUMA FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FIBRIN SEALANT MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FIBRIN SEALANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FIBRIN SEALANT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FIBRIN SEALANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FIBRIN SEALANT MARKET SIZE, BY PRE MIXED, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FIBRIN SEALANT MARKET SIZE, BY TWO COMPONENT KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FIBRIN SEALANT MARKET SIZE, BY MANUAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FIBRIN SEALANT MARKET SIZE, BY SPRAY APPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES FIBRIN SEALANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 57. CANADA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 58. CANADA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 59. CANADA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. CANADA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. MEXICO FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MEXICO FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 65. MEXICO FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 67. MEXICO FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. GERMANY FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. GERMANY FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 106. GERMANY FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 107. GERMANY FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 108. GERMANY FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. GERMANY FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 110. GERMANY FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. FRANCE FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. FRANCE FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 114. FRANCE FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 115. FRANCE FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 116. FRANCE FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. FRANCE FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. ITALY FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 130. ITALY FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 131. ITALY FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 132. ITALY FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. ITALY FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. SPAIN FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SPAIN FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 138. SPAIN FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 139. SPAIN FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 140. SPAIN FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. SPAIN FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 142. SPAIN FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. DENMARK FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. DENMARK FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 170. DENMARK FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 171. DENMARK FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 172. DENMARK FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. DENMARK FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 174. DENMARK FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. QATAR FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. QATAR FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 186. QATAR FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 187. QATAR FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 188. QATAR FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. QATAR FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 190. QATAR FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. FINLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. FINLAND FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 194. FINLAND FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 196. FINLAND FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FINLAND FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 198. FINLAND FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. EGYPT FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. EGYPT FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 218. EGYPT FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 219. EGYPT FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 220. EGYPT FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. EGYPT FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 222. EGYPT FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. TURKEY FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 226. TURKEY FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 228. TURKEY FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. TURKEY FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 230. TURKEY FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. NORWAY FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. NORWAY FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 242. NORWAY FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 243. NORWAY FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 244. NORWAY FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NORWAY FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. POLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. POLAND FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. POLAND FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 250. POLAND FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 251. POLAND FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 252. POLAND FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. POLAND FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 254. POLAND FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC FIBRIN SEALANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. CHINA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. CHINA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. CHINA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 275. CHINA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 276. CHINA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 277. CHINA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. CHINA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 279. CHINA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. INDIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. INDIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 283. INDIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 284. INDIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 285. INDIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. INDIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 287. INDIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. JAPAN FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. JAPAN FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 291. JAPAN FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 292. JAPAN FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 293. JAPAN FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. JAPAN FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 295. JAPAN FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 320. THAILAND FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. THAILAND FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 323. THAILAND FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 324. THAILAND FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 325. THAILAND FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. THAILAND FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 327. THAILAND FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 358. VIETNAM FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 359. VIETNAM FIBRIN SEALANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 360. TAIWAN FIBRIN SEALANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 361. TAIWAN FIBRIN SEALANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 362. TAIWAN FIBRIN SEALANT MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 363. TAIWAN FIBRIN SEALANT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 364. TAIWAN FIBRIN SEALANT MARKET SIZE, BY ORTHOPEDIC, 2018-2030 (USD MILLION)
TABLE 365. TAIWAN FIBRIN SEALANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 366. TAIWAN FIBRIN SEALANT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 367. TAIWAN FIBRIN S

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Fibrin Sealant market report include:
  • Baxter International Inc.
  • Ethicon Inc.
  • CSL Behring GmbH
  • B. Braun Melsungen AG
  • Omrix Biopharmaceuticals, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Hunan Kelun-Biotech Co., Ltd.
  • Shanghai Hualan Biological Engineering Inc.
  • Shanghai Haoyuan Biological Manufacturing Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 510.03 Million
Forecasted Market Value ( USD ) by 2030 $ 985.43 Million
Compound Annual Growth Rate14.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Fibrin Sealants - Global Strategic Business Report - Product Image

Fibrin Sealants - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Fibrin Sealants Market Report 2025 - Product Image

Fibrin Sealants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Fibrin Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Fibrin Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 100 Pages
  • Global
From
Human Fibrin Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Human Fibrin Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 88 Pages
  • Global
From
Fibrin Sealants Market 2024-2028 - Product Image

Fibrin Sealants Market 2024-2028

  • Report
  • 146 Pages
  • Global
From

About the Fibrin Sealant Market

Fibrin Sealant is a type of wound care product used to help close and heal wounds. It is a biologic product made from human plasma proteins that are used to help stop bleeding and promote healing. Fibrin Sealant is used to help close surgical incisions, reduce the risk of infection, and reduce the need for sutures. It is also used to help close traumatic wounds, such as those caused by burns or lacerations. Fibrin Sealant is often used in combination with other wound care products, such as dressings, to help promote healing. Fibrin Sealant is a growing market within the wound care industry. It is used in a variety of medical settings, including hospitals, clinics, and home care. It is also used in a variety of surgical procedures, including orthopedic, cardiovascular, and plastic surgery. Some companies in the Fibrin Sealant market include Baxter, CSL Behring, Grifols, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.